| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.057 | 0.04 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.065 | 0.05 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.05 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.05 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.085 | 0.05 |